TNFSF10 and cancer: It has been reported that constitutively active NF-κB signaling leads to TRAIL-resistance by upregulating XIAP in multiple human cancer cells [50], and in certain tumor cell types, NF-κB is the primary cause for TRAIL resistance [10].